loading

West Pharmaceutical Services Inc Azioni (WST) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
3.24%
872.30
844.90 805.00 804.60 766.50
Cost Of Revenue
0.98%
543.10
548.50 501.10 510.30 492.60
Gross Profit
11.07%
329.20
296.40 303.90 294.30 273.90
Selling, General, and Administrative
18.19%
117.60
99.50 - - -
Operating Income/Loss
1.13%
179.10
177.10 156.60 167.60 153.70
Income/Loss From Equity Method Investments
79.41%
6.10
3.40 3.90 2.10 5.00
Income/Loss From Continuing Operations Before Tax
0.00%
180.10
180.10 161.50 171.90 157.00
Income Tax Expense/Benefit
27.96%
32.20
44.70 33.30 34.00 30.20
Net Income/Loss
10.95%
154.00
138.80 132.10 140.00 131.80
Basic Average Shares
1.67%
70.80
72.00 - 72.20 72.20
Diluted Average Shares
1.52%
71.30
72.40 - 72.60 72.50
Basic Earnings Per Share
12.44%
2.17
1.93 1.83 1.94 1.82
Diluted Earnings Per Share
11.98%
2.15
1.92 1.82 1.92 1.82
ALC ALC
$64.11
price up icon 1.55%
$36.26
price up icon 1.45%
RMD RMD
$230.05
price up icon 1.46%
$87.29
price up icon 1.02%
BAX BAX
$24.35
price up icon 1.88%
$173.88
price up icon 6.13%
Capitalizzazione:     |  Volume (24 ore):